SOSolventum SOLV · NYSE
$85.10 -0.83% (-$0.71)
- Market cap
- $14.5B
- Enterprise value
- $19.4B
- P/E
- 10.1x
- Forward P/E
- 11.6x
- PEG
- 0.0x
- P/S
- 1.7x
- P/FCF
- -
- EV/EBITDA
- 7.5x
- ROIC
- 15.9%
- Gross margin
- 54.7%
- Net margin
- 17.3%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 1.9x
- Beta
- 0.70
- Free float
- 84.7%
About the company
Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Bryan C. Hanson
Employees
20,584
Headquarters
Eagan
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number